Charlotte’s Milestone Pharmaceuticals advancing heart drug
Joseph Oliveto, Milestone’s president and chief executive officer, said he expected the FDA to render a decision on the drug in about a year from now.
Read MorePosted by Jodi Leese Glusco | Apr 9, 2024
Joseph Oliveto, Milestone’s president and chief executive officer, said he expected the FDA to render a decision on the drug in about a year from now.
Read MorePosted by Jodi Leese Glusco | Apr 5, 2024
Our state’s rise as a powerhouse in life sciences can be attributed to a myriad of factors, including significant investments in research infrastructure, a robust talent pipeline, and a culture of collaboration that fosters innovation.
Read MorePosted by Jodi Leese Glusco | Apr 2, 2024
The Innovation Hub features a state-of-the-art lab space where single-use studies for freezing, transportation, and protection will be performed to support the biopharma industry’s cold chain logistics process.
Read MorePosted by Jodi Leese Glusco | Apr 2, 2024
The new North Carolina Plant Sciences Initiative (N.C. PSI) Startup Program helps researchers, alumni and others translate their ideas and discoveries into viable products and services that benefit agriculture.
Read MorePosted by Jodi Leese Glusco | Mar 19, 2024
The NCBiotech Venture Challenge is a statewide pitch competition in which 14 promising life sciences startup companies outside the Research Triangle area vie for access to key startup needs such as mentoring, visibility, and cash.
Read MorePosted by Jodi Leese Glusco | Feb 23, 2024
NCBiotech was founded in 1984, the first organization of its kind, as a catalyst for technology-based economic development in life sciences.
Read MorePosted by Jodi Leese Glusco | Jan 29, 2024
Posted by WRAL TechWire | Dec 22, 2023
North Carolina’s booming biopharmaceutical manufacturing industry will need at least 8,000 new workers by the end of 2026. Will the state be able to provide that workforce? And how so? A new report examines the issues.
Read More